The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
NCT05254834 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7435
Last updated 2025-08-22
Summary
This protocol is a case-control, multicenter, diagnostic study to collect blood samples to support the development of blood-based screening tests for multiple cancers.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Freenome Test
Participants who provide informed consent, meet the eligibility criteria and provide a blood sample for this study will be enrolled.
Sponsors & Collaborators
-
Freenome Holdings Inc.
lead INDUSTRY
Eligibility
- Min Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-02-15
- Primary Completion
- 2024-07-24
- Completion
- 2025-07-12
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Universal Germline Testing in the Community
NCT05416710 ·Status: UNKNOWN
-
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
NCT03662204 ·Status: COMPLETED
-
The STRIVE Study: Development of a Blood Test for Early Detection of Multiple Cancer Types
NCT03085888 ·Status: COMPLETED
-
Non Invasive Cancer Test (NICT): a Proof of Principle Study.
NCT03019471 ·Status: RECRUITING
-
Genomic Analysis of Families With a History of Discordant Cancers
NCT04860453 ·Status: RECRUITING
-
Collection of Blood From Patients With Cancer
NCT00034216 ·Status: RECRUITING
-
Collection of Blood, Bone Marrow, Tumor or Tissue Samples
NCT00043615 ·Status: COMPLETED
-
Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay
NCT02586389 ·Status: RECRUITING
-
Collection of Biological Specimens and Associated Health Information
NCT06369441 ·Status: NOT_YET_RECRUITING
-
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
NCT02178163 ·Status: RECRUITING ·Phase: NA
-
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT06995898 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
NCT00242723 ·Status: RECRUITING
-
A Genotype-Phenotype Urothelial Cancer Registry
NCT00902590 ·Status: ACTIVE_NOT_RECRUITING
-
Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer Patients
NCT02706652 ·Status: TERMINATED
-
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
NCT00026884 ·Status: RECRUITING
-
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
NCT00026663 ·Status: COMPLETED
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
NCT01441089 ·Status: RECRUITING
-
Detection of Tumor DNA in Blood Samples From Cancer Patients
NCT02288754 ·Status: UNKNOWN
-
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
NCT05366881 ·Status: RECRUITING
-
Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
NCT00003329 ·Status: COMPLETED
-
Multi-Omics Noninvasive Inspection of TumOr Risk for Gastric Cancer
NCT04947995 ·Status: UNKNOWN
-
Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
NCT01542333 ·Status: COMPLETED
-
A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
NCT03617939 ·Status: RECRUITING
-
Circulating Tumor DNA Exposure in Peripheral Blood
NCT03517332 ·Status: UNKNOWN
-
Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
NCT03061305 ·Status: TERMINATED